Published in J Bone Miner Res on June 01, 2008
Osteoblast connexin43 modulates skeletal architecture by regulating both arms of bone remodeling. Mol Biol Cell (2011) 1.63
Connexins: a myriad of functions extending beyond assembly of gap junction channels. Cell Commun Signal (2009) 1.49
The regulation of runt-related transcription factor 2 by fibroblast growth factor-2 and connexin43 requires the inositol polyphosphate/protein kinase Cδ cascade. J Bone Miner Res (2013) 1.04
Beyond gap junctions: Connexin43 and bone cell signaling. Bone (2012) 1.02
The transcriptional activity of osterix requires the recruitment of Sp1 to the osteocalcin proximal promoter. Bone (2011) 1.02
Characterization of hTERT-immortalized osteoblast cell lines generated from wild-type and connexin43-null mouse calvaria. Am J Physiol Cell Physiol (2010) 0.98
A dominant loss-of-function GJA1 (Cx43) mutant impairs parturition in the mouse. Biol Reprod (2009) 0.91
Molecular mechanisms of osteoblast/osteocyte regulation by connexin43. Calcif Tissue Int (2013) 0.91
Structure and functional studies of N-terminal Cx43 mutants linked to oculodentodigital dysplasia. Mol Biol Cell (2012) 0.88
Oogenesis defects in a mutant mouse model of oculodentodigital dysplasia. Dis Model Mech (2009) 0.85
CONNEXIN 43 AND BONE: NOT JUST A GAP JUNCTION PROTEIN. Actual osteol (2011) 0.84
Up-regulation of BMP2/4 signaling increases both osteoblast-specific marker expression and bone marrow adipogenesis in Gja1Jrt/+ stromal cell cultures. Mol Biol Cell (2015) 0.80
Connexins in the skeleton. Semin Cell Dev Biol (2015) 0.78
Effect of magnesium ion on human osteoblast activity. Braz J Med Biol Res (2016) 0.78
Regulation of gap junction function and Connexin 43 expression by cytochrome P450 oxidoreductase (CYPOR). Biochem Biophys Res Commun (2011) 0.76
Neuropeptide Y, substance P, and human bone morphogenetic protein 2 stimulate human osteoblast osteogenic activity by enhancing gap junction intercellular communication. Braz J Med Biol Res (2015) 0.75
Connexinopathies: a structural and functional glimpse. BMC Cell Biol (2016) 0.75
The C-terminal domain of connexin43 modulates cartilage structure via chondrocyte phenotypic changes. Oncotarget (2016) 0.75
Multicolor and electron microscopic imaging of connexin trafficking. Science (2002) 5.60
Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis. Nature (2010) 4.10
Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med (2006) 3.59
The histone mark H3K36me3 regulates human DNA mismatch repair through its interaction with MutSα. Cell (2013) 2.87
Pannexin 1 and pannexin 3 are glycoproteins that exhibit many distinct characteristics from the connexin family of gap junction proteins. J Cell Sci (2007) 2.41
Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol (2009) 2.26
Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res (2008) 2.03
A Gja1 missense mutation in a mouse model of oculodentodigital dysplasia. Development (2005) 1.93
MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem (2008) 1.86
Implications and challenges of connexin connections to cancer. Nat Rev Cancer (2010) 1.85
Pannexin channels are not gap junction hemichannels. Channels (Austin) (2011) 1.84
Rho signaling regulates pannexin 1-mediated ATP release from airway epithelia. J Biol Chem (2011) 1.76
The biochemistry and function of pannexin channels. Biochim Biophys Acta (2012) 1.70
Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs. J Am Coll Cardiol (2007) 1.62
RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages. PLoS Pathog (2008) 1.49
Gap junction remodeling in skin repair following wounding and disease. Physiology (Bethesda) (2013) 1.49
Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. Cancer Res (2006) 1.48
Hemozoin-inducible proinflammatory events in vivo: potential role in malaria infection. J Immunol (2004) 1.46
Oculodentodigital dysplasia-causing connexin43 mutants are non-functional and exhibit dominant effects on wild-type connexin43. J Biol Chem (2005) 1.46
Glycosylation regulates pannexin intermixing and cellular localization. Mol Biol Cell (2009) 1.45
Deletion of Panx3 Prevents the Development of Surgically Induced Osteoarthritis. J Mol Med (Berl) (2015) 1.45
Forced mobilization accelerates pathogenesis: characterization of a preclinical surgical model of osteoarthritis. Arthritis Res Ther (2007) 1.43
Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes. J Biol Chem (2005) 1.42
Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. J Biol Chem (2002) 1.37
KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay. BMC Cancer (2009) 1.33
In vitro and in vivo uncaging and bioluminescence imaging by using photocaged upconversion nanoparticles. Angew Chem Int Ed Engl (2012) 1.33
The induction of CCN2 by TGFbeta1 involves Ets-1. Arthritis Res Ther (2006) 1.33
Lysosomal and proteasomal degradation play distinct roles in the life cycle of Cx43 in gap junctional intercellular communication-deficient and -competent breast tumor cells. J Biol Chem (2003) 1.32
Marital transitions and mental health: are there gender differences in the short-term effects of marital status change? Soc Sci Med (2005) 1.30
Connexin 43 mediated gap junctional communication enhances breast tumor cell diapedesis in culture. Breast Cancer Res (2005) 1.27
Caveolin-1 and -2 interact with connexin43 and regulate gap junctional intercellular communication in keratinocytes. Mol Biol Cell (2007) 1.23
TNFalpha suppresses link protein and type II collagen expression in chondrocytes: Role of MEK1/2 and NF-kappaB signaling pathways. J Cell Physiol (2003) 1.22
Evaluation of mammary gland development and function in mouse models. J Vis Exp (2011) 1.22
Mechanisms of Cx43 and Cx26 transport to the plasma membrane and gap junction regeneration. J Cell Sci (2005) 1.21
Pannexin1 regulates α1-adrenergic receptor- mediated vasoconstriction. Circ Res (2011) 1.21
In vitro and in vivo germ line potential of stem cells derived from newborn mouse skin. PLoS One (2011) 1.20
Down-regulation of Cx43 by retroviral delivery of small interfering RNA promotes an aggressive breast cancer cell phenotype. Cancer Res (2005) 1.17
Connexins and gap junctions in mammary gland development and breast cancer progression. J Membr Biol (2007) 1.15
Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation. J Immunol (2004) 1.13
Functional characterization of a GJA1 frameshift mutation causing oculodentodigital dysplasia and palmoplantar keratoderma. J Biol Chem (2006) 1.10
Differential potency of dominant negative connexin43 mutants in oculodentodigital dysplasia. J Biol Chem (2007) 1.10
Selective assembly of connexin37 into heterocellular gap junctions at the oocyte/granulosa cell interface. J Cell Sci (2004) 1.09
Gap junctions assemble in the presence of cytoskeletal inhibitors, but enhanced assembly requires microtubules. Exp Cell Res (2002) 1.09
Conjugation mediates transfer of the Ll.LtrB group II intron between different bacterial species. Mol Microbiol (2004) 1.08
Effect of carcinogenic acrolein on DNA repair and mutagenic susceptibility. J Biol Chem (2012) 1.07
Functional characterization of oculodentodigital dysplasia-associated Cx43 mutants. Cell Commun Adhes (2006) 1.07
Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo. Clin Cancer Res (2005) 1.05
Myeloid-related proteins rapidly modulate macrophage nitric oxide production during innate immune response. J Immunol (2008) 1.05
Transforming growth factor alpha suppression of articular chondrocyte phenotype and Sox9 expression in a rat model of osteoarthritis. Arthritis Rheum (2007) 1.04
Functional domain mapping and selective trans-dominant effects exhibited by Cx26 disease-causing mutations. J Biol Chem (2004) 1.03
Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2013) 1.03
Pannexin1 and pannexin3 delivery, cell surface dynamics, and cytoskeletal interactions. J Biol Chem (2010) 1.03
The stress model of chronic pain: evidence from basal cortisol and hippocampal structure and function in humans. Brain (2013) 1.02
Reduced arteriolar conducted vasoconstriction in septic mouse cremaster muscle is mediated by nNOS-derived NO. Cardiovasc Res (2005) 1.01
The tumor-suppressive function of Connexin43 in keratinocytes is mediated in part via interaction with caveolin-1. Cancer Res (2010) 1.01
Na,K-ATPase from mice lacking the gamma subunit (FXYD2) exhibits altered Na+ affinity and decreased thermal stability. J Biol Chem (2005) 1.00
Interplay between paracrine signaling and gap junctional communication in ovarian follicles. J Cell Sci (2004) 0.99
Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer. Clin Cancer Res (2002) 0.99
Pannexin 3 is a novel target for Runx2, expressed by osteoblasts and mature growth plate chondrocytes. J Bone Miner Res (2011) 0.99
Methylation status of TUSC3 is a prognostic factor in ovarian cancer. Cancer (2012) 0.99
Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport. Biomed Pharmacother (2011) 0.99
In vivo analysis of undocked connexin43 gap junction hemichannels in ovarian granulosa cells. J Cell Sci (2007) 0.98
Decreased levels of connexin43 result in impaired development of the mammary gland in a mouse model of oculodentodigital dysplasia. Dev Biol (2008) 0.97
Mechanisms linking connexin mutations to human diseases. Cell Tissue Res (2014) 0.97
Implications of pannexin 1 and pannexin 3 for keratinocyte differentiation. J Cell Sci (2010) 0.97
S-nitrosylation inhibits pannexin 1 channel function. J Biol Chem (2012) 0.96
Analysis of oocyte-like cells differentiated from porcine fetal skin-derived stem cells. Stem Cells Dev (2011) 0.96
Egr-1 inhibits the expression of extracellular matrix genes in chondrocytes by TNFalpha-induced MEK/ERK signalling. Arthritis Res Ther (2009) 0.96
Expression of pannexin isoforms in the systemic murine arterial network. J Vasc Res (2012) 0.95
Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium. Cancer Sci (2012) 0.94
PROGINS receptor gene polymorphism is associated with endometriosis. Fertil Steril (2002) 0.94
Metabolite profiling and pharmacokinetics of herbal compounds following oral administration of a cardiovascular multi-herb medicine (Qishen yiqi pills) in rats. Curr Drug Metab (2012) 0.94
Loss of pannexin 1 attenuates melanoma progression by reversion to a melanocytic phenotype. J Biol Chem (2012) 0.94
Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism. Carcinogenesis (2006) 0.94
Diverse subcellular distribution profiles of pannexin 1 and pannexin 3. Cell Commun Adhes (2008) 0.94
Acute stress contributes to individual differences in pain and pain-related brain activity in healthy and chronic pain patients. J Neurosci (2013) 0.93